Boston Scientific (BSX) vs Koninklijke Philips N.V. NY Registry Shares (PHG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Koninklijke Philips N.V. NY Registry Shares (PHG) has outperformed Boston Scientific (BSX) over the past year, losing 13.5% versus a loss of 56.3%. Over five years, BSX leads with a -3.4% price change compared with -46.0% for PHG. Boston Scientific is the larger company by market cap ($60.26 billion vs $23.55 billion), about 2.6 times the size.
On valuation, Boston Scientific trades at a lower forward P/E (12.3x vs 12.7x for Koninklijke Philips N.V. NY Registry Shares). Koninklijke Philips N.V. NY Registry Shares pays a dividend yielding 3.53%, while Boston Scientific does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BSX | PHG |
|---|---|---|
| Share price | $41.58 | $24.09 |
| Market cap | $60.26B | $23.55B |
| 1-day change | -1.45% | -0.25% |
| YTD return | -56.01% | -11.12% |
| 1-year return | -56.26% | -13.51% |
| 5-year return | -3.35% | -46.00% |
| P/E ratio (TTM) | 16.83 | 17.98 |
| Forward P/E | 12.29 | 12.72 |
| EPS (TTM) | $2.47 | $1.34 |
| Dividend yield | 0.00% | 3.53% |
| Annual dividend | $0.00 | $0.85 |
| Revenue (latest FY) | $20.07B | — |
| Revenue growth (YoY) | +19.87% | — |
| Net income (latest FY) | $2.89B | — |
| Gross margin | 69.01% | — |
| Operating margin | 18.00% | — |
| Net margin | 14.41% | — |
| 52-week high | $105.65 | $33.44 |
| 52-week low | $41.50 | $23.62 |
| Distance from 52-week high | -60.64% | -27.96% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +44.06% | +32.92% |
| Average volume | 19.67M | 984.16K |
| Shares outstanding | 1.45B | 977.43M |
| Employees | 59,000 | 63,670 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Boston Scientific is about 2.6 times larger than Koninklijke Philips N.V. NY Registry Shares by market value ($60.26B vs $23.55B).
- PHG has outperformed BSX by 42.8 percentage points over the past year.
- Koninklijke Philips N.V. NY Registry Shares offers a meaningfully higher dividend yield (3.53% vs 0.00%).
About Boston Scientific
BSX stock →Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.
Healthcare · Medical Devices · 59,000 employees
About Koninklijke Philips N.V. NY Registry Shares
PHG stock →Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.
Healthcare · Medical Devices · 63,670 employees
BSX vs PHG FAQ
Which is bigger, Boston Scientific or Koninklijke Philips N.V. NY Registry Shares?
Boston Scientific (BSX) is larger, with a market capitalization of $60.26B compared with $23.55B for Koninklijke Philips N.V. NY Registry Shares (PHG).
Which stock has performed better over the past year, BSX or PHG?
PHG returned -13.51% over the past 12 months, compared with -56.26% for BSX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, BSX or PHG?
BSX has the lower trailing P/E at 16.8, versus 18.0 for PHG. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Boston Scientific or Koninklijke Philips N.V. NY Registry Shares?
Koninklijke Philips N.V. NY Registry Shares pays a dividend yielding 3.53%, while Boston Scientific does not currently pay a regular dividend.
Are Boston Scientific and Koninklijke Philips N.V. NY Registry Shares in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.